A Single-center, Double-blind for Cenerimod, Open-label for Moxifloxacin, Placebo-controlled, Parallel-group, Randomized Study in Healthy Male and Female Subjects to Investigate I: the Effect of Cenerimod on the QTc Interval II: the Effect of Cenerimod on the Pharmacokinetics of Combined Oral Contraceptives III: the Effect of Charcoal on the Pharmacokinetics of Cenerimod
Latest Information Update: 21 Nov 2022
At a glance
- Drugs Cenerimod (Primary) ; Charcoal; Ethinylestradiol/levonorgestrel; Moxifloxacin
- Indications Systemic lupus erythematosus
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Idorsia Pharmaceuticals
Most Recent Events
- 22 Oct 2021 Status changed from active, no longer recruiting to completed.
- 08 Oct 2021 Planned End Date changed from 1 Aug 2021 to 1 Oct 2021.
- 09 Feb 2021 Planned End Date changed from 1 Feb 2021 to 1 Aug 2021.